ARTICLE | Clinical News
Rezular averapamil gastrointestinal data
February 25, 2008 8:00 AM UTC
In an open-label, 3-way crossover, pharmacokinetic study in 16 volunteers, there were no detectable levels of the S-isomer after treatment with 80 mg Rezular arverapamil under fasting conditions. Unde...